Anthony Rainho

Anthony Rainho

Auto-generated profile, based on publicly available information

Anthony Rainho

Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA

Research Focus & Metrics

Representative Publications

View All Publications
29 August 2024 in ACG Case Reports Journal
Verified
Journal Article
Open access
MMMary McGrath
Mary McGrath
CGCalvin Geng
Calvin Geng
ARAnthony Rainho
Anthony Rainho
EFEsteban Figueroa
Esteban Figueroa
Splenic abscesses are typically infectious in nature but have rarely been reported as an extraintestinal manifestation of inflammatory bowel disease, particularly of Crohn's disease. In the United States, reported cases are even more scarce. We present a case of aseptic splenic abscess with concomitant Sweet syndrome in a middle-aged woman with newly diagnosed Crohn's disease. Extensive workup was required to reach final diagnosis, and she rapidly improved with corticosteroid therapy and has been maintained on risankizumab. We aim to contribute to limited data and heighten clinician awareness of these atypical extraintestinal manifestations.

1 January 2025 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
MSMatthew Schliep
Matthew Schliep
BWBrian Jackson Wentworth
Brian Jackson Wentworth
IBIndira Bhavsar-Burke
Indira Bhavsar-Burke
ARAnthony Rainho
Anthony Rainho
MCMegha Chiruvella
Megha Chiruvella
MGMarwan Ghabril
Marwan Ghabril
Background and Aims: Patients experience more complications of portal hypertension as liver disease progresses, many of which can be managed by transjugular intrahepatic portosystemic shunt (TIPS) insertion. Controversy surrounds the association of age with TIPS‐related complications. We sought to evaluate the effect of age on TIPS‐associated outcomes, including hospital admissions. Methods: This retrospective, bicentric cohort study included patients who underwent TIPS insertion between January 1, 2006, and December 31, 2016. The primary outcome of the study was predictors of liver‐related hospital admission within 12 months of TIPS insertion between patients < 70 years and ≥ 70 years old. Secondary outcomes included mortality at 12 months and MELD‐Na score at 90 days following TIPS placement. Results: A total of 593 patients were included in the study—487 patients were less than 70 years old while 106 patients were 70 years of age or older. Near equal percentages of elderly and nonelderly patients were admitted with post‐TIPS complications within 12 months of insertion (29.2% v. 29.0%, p = 0.91). Pre‐existing diagnoses of diabetes and/or hypertension, hepatic hydrothorax, as well as serum creatinine and/or serum sodium at the time of TIPS insertion were associated with TIPS‐related admissions within the first 12 months of shunt insertion. Conclusion: TIPS placement in selected older patients can be safe. Age should not be a strict contraindication for TIPS insertion, but discussion regarding risks and benefits of the procedure should be individualized.

5 August 2025 in VideoGIE
Verified
Journal Article
Open access
ARAnthony M. Rainho
Anthony M. Rainho
TETsola A. Efejuku
Tsola A. Efejuku
RHRebecca M. Haug
Rebecca M. Haug
MRMark J. Radlinski
Mark J. Radlinski
DSDaniel S. Strand
Daniel S. Strand
RBRoss C.D. Buerlein
Ross C.D. Buerlein
Uncovered self-expandable metal stents (UC-SEMSs) are used for unresectable pancreaticobiliary malignancies. These stents can fray, causing malfunction, ulceration, and perforation. Trimming frayed UC-SEMSs is challenging and risks injury to adjacent structures. Argon plasma coagulation (APC) has shown success transecting and shortening stent wires, but the technique can be cumbersome and time-consuming and risk tissue injury. No standardized power settings exist (65-85 W; 0.5-2 L/min). We present 2 cases of distorted UC-SEMSs requiring transection using a bipolar endoscopic system designed for over-the-scope clip (OTSC) removal. Electrosurgical generator costs are comparable (U.S. $3000-$7000), and single-use catheters cost U.S. $250-$500, making relative costs similar. Two distorted indwelling UC-SEMSs were transected with a bipolar OTSC removal device to accommodate further interventions. Electrical pulses fired only with adequate metal contact. The paired generator required several minutes of charging; alternative generators were incompatible. In both cases, aberrant UC-SEMSs were successfully restructured using an OTSC removal system without adverse events or tissue injury. APC can transect UC-SEMS wires, but these cases show a safe, effective, off-label method using an OTSC removal system.